<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23869549</PMID>
        <DateCompleted>
            <Year>2014</Year>
            <Month>03</Month>
            <Day>31</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1557-8976</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>26</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Viral immunology</Title>
                <ISOAbbreviation>Viral Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>268-76</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1089/vim.2012.0087</ELocationID>
            <Abstract>
                <AbstractText>Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants and the elderly worldwide. The significant morbidity and mortality associated with this infection underscores the urgent need for development of RSV vaccine. In this study, we first show that intranasal administration of RSV glycoprotein core fragment (Gcf) to neonatal mice can induce systemic humoral immune responses and protective immunity against RSV without causing lung eosinophilia, although antibody response was shifted to a Th2 response. Next, we examined whether the presence of maternal anti-RSV antibodies would affect the responsiveness and protection efficacy of Gcf in newborn mice, since infants can possess RSV-specific maternal antibodies due to frequent RSV re-infections to adults. Intranasal administration of Gcf induced antibody response and increased IFNÎ³ secretion and protected mice against RSV challenge without severe lung eosinophilia, even in the presence of high levels of RSV-specific maternal antibodies. Thus, our findings suggest that Gcf may be an effective and safe RSV vaccine during the neonatal period.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Noh</LastName>
                    <ForeName>Youran</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory Science Division , International Vaccine Institute, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shim</LastName>
                    <ForeName>Byoung-Shik</ForeName>
                    <Initials>BS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheon</LastName>
                    <ForeName>In Su</ForeName>
                    <Initials>IS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rho</LastName>
                    <ForeName>Semi</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Hee Joo</ForeName>
                    <Initials>HJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Youngjoo</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Chang-Yuil</ForeName>
                    <Initials>CY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Man Ki</ForeName>
                    <Initials>MK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Jae-Ouk</ForeName>
                    <Initials>JO</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>07</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Viral Immunol</MedlineTA>
            <NlmUniqueID>8801552</NlmUniqueID>
            <ISSNLinking>0882-8245</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D022261">Respiratory Syncytial Virus Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>82115-62-6</RegistryNumber>
                <NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName>
                <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004802" MajorTopicYN="N">Eosinophilia</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D022261" MajorTopicYN="N">Respiratory Syncytial Virus Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012136" MajorTopicYN="N">Respiratory Syncytial Viruses</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23869549</ArticleId>
            <ArticleId IdType="doi">10.1089/vim.2012.0087</ArticleId>
            <ArticleId IdType="pmc">PMC3739953</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2000 Jun 15;164(12):6583-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10843718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(3):e34331</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22479601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2001 Mar 1;183(5):823-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Med Chem. 2001 Jul;8(9):1057-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11472241</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2001 Oct 1;167(7):3910-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11564809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2001 Dec 1;184(11):1456-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11709789</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 2002 May;70(5):2725-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11953420</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2002 Nov 18;196(10):1381-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12438429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S6-10; discussion S10-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12671447</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2003 Jul 28;21(24):3479-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12850364</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 2003 Nov;143(5 Suppl):S112-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14615709</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 2004 Jan;89(1):52-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14709507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2004 Jul;4(7):553-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15229474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 1969 Apr;89(4):422-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4305198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 1981 May;98(5):708-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7229749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Vet Med Assoc. 1985 Jan 15;186(2):149-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2982774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Vet Res. 1985 Jul;46(7):1498-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2992327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Dis Child. 1986 Jun;140(6):543-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3706232</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 1986 Aug;24(2):304-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3755731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1987 Aug;84(16):5625-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2441388</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1988 Oct;62(10):3907-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3047432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1991 Jun;65(6):3374-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2033675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 1991 Mar;9(3):185-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2042390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 1991 Sep;72 ( Pt 9):2091-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1895054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1991 Oct;65(10):5425-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1895391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 1992 Jan;120(1):28-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1731020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 1992 Aug;24(3):297-314</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1413989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1996 May;70(5):2852-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8627759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 1996 Mar;48(3):253-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8801286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 1997 Feb;15(3):273-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9139485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 1997 Feb;15(3):287-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9139488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 1997 Apr 14;230(2):155-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9143271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1997 Oct;176(4):884-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9333145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Today. 1998 Apr;19(4):150-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9577089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1998 Dec 1;161(11):5952-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9834076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1999 Jul;73(7):5637-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10364313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2007 Mar 1;178(5):2667-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17312108</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2007 Aug;26(8):733-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17848887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2008 Jan;41(1):38-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18340669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2009 Jan;39(1):36-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19089811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 2009 Feb;154(2):296-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19150677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin. 2010 Jun;6(6):482-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20671419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Anti Infect Ther. 2010 Dec;8(12):1371-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21133663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2011 Jan;239(1):149-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21198670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2011 Mar;12(3):189-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21321588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(2):e32226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22384186</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2001 Jan 1;183(1):16-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11076709</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>